Affiliation:
1. Assistant Professor, Department of General Medicine
2. 3 Year Post Graduate, Department Of General Medicine
Abstract
Background: Dengue is the most rapidly spreading mosquito borne viral disease in the world. Dengue
viruses are avivirus, which include four serotypes 1, 2, 3 and 4. Clinical expression of dengue virus
infection vary from asymptomatic infection to severe dengue with shock. Incidence has increased 30- fold in the last 50 years
with increasing geographic expansion to new countries and, in the present decade, from urban to rural settings. At present,
dengue fever (DF) causes more illness and death than any other arboviral disease of humans. Aims and objectives: To
determine the value of serum albumin and C-reactive protein (CRP) in the assessment of severity of dengue infection in patients
admitted to SNMC and HSK hospital. Materials and methods: Record based study done on patients admitted to general
medicine department of S Nijalingappa Medical College and HSK hospital, bagalkot, Karnataka. Patients with Dengue NS1
Ag or IgM positive are included in the study after meeting inclusion and exclusion criteria. Results: A total of 65 patients were
studied according to the inclusion criteria. Majority of the patients were between 20-40years of age with 56.9% being male
patients and 43.1% were females. 40% of the patients had dengue without warning signs, 52.3% had dengue with warning
signs and 7.7% had severe dengue. Mean serum albumin of 2.66g/dl was seen in severe dengue group whereas a value of
3.65g/dl and 3.06g/dl was seen in dengue without warning signs and dengue with warning signs respectively. Mean CRP of
severe dengue group was 98.84mg/L whereas it was 9.49mg/L and 53.60mg/L among dengue without warning signs and
dengue with warning signs respectively. Conclusion: Serum albumin and C-reactive protein can be used as potential markers
to predict severity of illness in dengue infection.
Reference18 articles.
1. World Health Organization and Tropical Diseases Research. Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization; 2009: new edition.
2. Simmons CP, Farrar JJ, Nguyen VV, Wills B. Dengue. N Engl J Med 2012;366:1423.
3. Guzman MG, Harris E. Dengue. Lancet 2015;385:453.
4. Kularatne SA. Dengue fever. BMJ 2015;351:h4661
5. Perez JGR, Clark GG, Gubler DJ, Reiter P, Sanders EJ. Dengue and Dengue hemorrhagic fever. Lancet 1998;352:971-77.